Mix-and-match vaccine highly effective against Covid, says Lancet study

Mix-and-match vaccine highly effective against Covid, says Lancet study

People who received the first dose of the Oxford-AstraZeneca Covid-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca, according to a nationwide study in Sweden.

London, October 18

People who received the first dose of the Oxford-AstraZeneca Covid-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca, according to a nationwide study in Sweden.

Since the use of AstraZeneca’s vector-based vaccine against Covid-19 was halted for those below 65 years of age due to safety concerns, all individuals in Sweden who had already received their first dose of this vaccine were recommended an mRNA vaccine as their second dose. “Having received any of the approved vaccines is better compared to no vaccine, and two doses are better than one,” said Peter Nordstrom, a professor at Umea University, Sweden. “However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received the first dose of a vector-based vaccine, as compared to people having received the vector-based vaccine for both doses,” Nordstrom said.

The study, published in The Lancet Regional Health - Europe journal on Monday, is based on nationwide registry data from the Public Health Agency of Sweden, the National Board of Health and Welfare, and Statistics Sweden.

In the main analysis, about 7 lakh individuals were included. During a 2.5-month average follow-up period after the second dose, the study showed a 67 per cent lower risk of infection for the combination of AstraZeneca and Pfizer vaccine shots.

There was a 79% lower risk of infection for AstraZeneca and Moderna vaccine shots, compared to unvaccinated individuals, the researchers said.

For people having received two doses of the AstraZeneca vaccine, known as Covishield in India, the risk reduction was 50%, they said. — PTI

13,596 fresh cases

TOTAL DEATHS 4,52,290

ACTIVE CASES 1,89,694

166 deaths in 24 hours

Survey findings

  • 67% lower risk of infection for the combination of AstraZeneca and Pfizer vaccine shots
  • 79% lower risk for AstraZeneca and Moderna jabs, compared with unvaccinated individuals
  • 50% risk reduction for people having received two doses of the AstraZeneca vaccine (Covishield)

Tribune Shorts


Top Stories

There is no UPA, Mamata Banerjee after meeting Sharad Pawar

There is no UPA, says Mamata Banerjee after meeting Sharad Pawar

Banerjee is on a three-day visit to Mumbai

International arrivals running smoothly; 1,013 passengers completed arrival formalities: Delhi airport

4 passengers from UK, Netherlands test positive for Covid, samples sent for genome sequencing

All four have been admitted to the LNJP Hospital, where a de...

Manjinder Singh Sirsa quits as DSGMC president

Manjinder Singh Sirsa quits as DSGMC president, joins BJP

The BJP tweeted a video of his joining the party

Mysuru on alert as 72 nursing students test positive for Covid

Mysuru on alert as 72 nursing students test positive for Covid

As many as 43 students of Kaveri Nursing hostel and 29 stude...

Cities

View All